Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial.
Saved in:
| Title: | Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial. |
|---|---|
| Authors: | Ferrero S; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Pastore A; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Scholz CW; Department of Oncology and Hematology, Vivantes Klinikum, Berlin, Germany., Forstpointner R; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Pezzutto A; Charité University Medicine, Department of Hematology and Oncology, Berlin, Germany., Bergmann L; Medical Clinic II, University Hospital, Frankfurt, Germany., Trümper L; Department of Hematology and Oncology, Georg-August Universiität, Göttingen, Germany., Finke J; Hematology/Oncology, University Medical Center, Freiburg, Germany., Keller U; III Medical Department, Technische Universität München, Munich, Germany., Ghione P; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Passera R; Biostatistician, Division of Nuclear Medicine, Città della Salute e della Scienza, University of Torino, Torino, Italy., Hiddemann W; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Weigert O; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Unterhalt M; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Dreyling M; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany. |
| Source: | Leukemia [Leukemia] 2016 Apr; Vol. 30 (4), pp. 984-7. Date of Electronic Publication: 2015 Aug 05. |
| Publication Type: | Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26242461 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ferrero+S%22">Ferrero S</searchLink>; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Pastore+A%22">Pastore A</searchLink>; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.<br /><searchLink fieldCode="AU" term="%22Scholz+CW%22">Scholz CW</searchLink>; Department of Oncology and Hematology, Vivantes Klinikum, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Forstpointner+R%22">Forstpointner R</searchLink>; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.<br /><searchLink fieldCode="AU" term="%22Pezzutto+A%22">Pezzutto A</searchLink>; Charité University Medicine, Department of Hematology and Oncology, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bergmann+L%22">Bergmann L</searchLink>; Medical Clinic II, University Hospital, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Trümper+L%22">Trümper L</searchLink>; Department of Hematology and Oncology, Georg-August Universiität, Göttingen, Germany.<br /><searchLink fieldCode="AU" term="%22Finke+J%22">Finke J</searchLink>; Hematology/Oncology, University Medical Center, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Keller+U%22">Keller U</searchLink>; III Medical Department, Technische Universität München, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Ghione+P%22">Ghione P</searchLink>; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Passera+R%22">Passera R</searchLink>; Biostatistician, Division of Nuclear Medicine, Città della Salute e della Scienza, University of Torino, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Hiddemann+W%22">Hiddemann W</searchLink>; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.<br /><searchLink fieldCode="AU" term="%22Weigert+O%22">Weigert O</searchLink>; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.<br /><searchLink fieldCode="AU" term="%22Unterhalt+M%22">Unterhalt M</searchLink>; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.<br /><searchLink fieldCode="AU" term="%22Dreyling+M%22">Dreyling M</searchLink>; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2016 Apr; Vol. 30 (4), pp. 984-7. <i>Date of Electronic Publication: </i>2015 Aug 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26242461 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/leu.2015.215 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 984 Titles: – TitleFull: Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ferrero S – PersonEntity: Name: NameFull: Pastore A – PersonEntity: Name: NameFull: Scholz CW – PersonEntity: Name: NameFull: Forstpointner R – PersonEntity: Name: NameFull: Pezzutto A – PersonEntity: Name: NameFull: Bergmann L – PersonEntity: Name: NameFull: Trümper L – PersonEntity: Name: NameFull: Finke J – PersonEntity: Name: NameFull: Keller U – PersonEntity: Name: NameFull: Ghione P – PersonEntity: Name: NameFull: Passera R – PersonEntity: Name: NameFull: Hiddemann W – PersonEntity: Name: NameFull: Weigert O – PersonEntity: Name: NameFull: Unterhalt M – PersonEntity: Name: NameFull: Dreyling M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2016 Apr Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 30 – Type: issue Value: 4 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |